High Court Seeks Path To Limited Ruling On 'Skinny Labels'

By Ryan Davis · April 29, 2026, 9:24 PM EDT

The U.S. Supreme Court on Wednesday appeared reluctant to craft new standards for deciding whether makers of generic drugs that use so-called skinny labels have encouraged others to infringe patents, with...

To view the full article, register now.

Documents

Case Information

Case Title

Hikma Pharmaceuticals USA Inc., et al., Petitioners v. Amarin Pharma, Inc., et al.

Case Number

24-889

Court

Supreme Court

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

February 19, 2025